Your browser is no longer supported. Please, upgrade your browser.
Settings
BIOS BioScrip, Inc. daily Stock Chart
BIOS [NASD]
BioScrip, Inc.
Index- P/E- EPS (ttm)-1.07 Insider Own0.60% Shs Outstand127.77M Perf Week11.42%
Market Cap361.59M Forward P/E- EPS next Y-0.16 Insider Trans0.00% Shs Float127.07M Perf Month15.51%
Income-135.40M PEG- EPS next Q-0.12 Inst Own88.90% Short Float8.52% Perf Quarter12.75%
Sales768.00M P/S0.47 EPS this Y-136.10% Inst Trans1.25% Short Ratio19.71 Perf Half Y4.81%
Book/sh-0.78 P/B- EPS next Y51.50% ROA-11.40% Target Price3.79 Perf Year11.86%
Cash/sh0.24 P/C11.89 EPS next 5Y10.00% ROE83.50% 52W Range1.80 - 3.39 Perf YTD-2.75%
Dividend- P/FCF- EPS past 5Y-39.20% ROI-19.80% 52W High-16.52% Beta0.17
Dividend %- Quick Ratio1.30 Sales past 5Y6.60% Gross Margin33.70% 52W Low57.22% ATR0.10
Employees1727 Current Ratio1.70 Sales Q/Q-22.60% Oper. Margin-1.20% RSI (14)70.03 Volatility4.58% 4.06%
OptionableYes Debt/Eq- EPS Q/Q33.30% Profit Margin-8.90% Rel Volume1.02 Prev Close2.77
ShortableYes LT Debt/Eq- EarningsMay 10 BMO Payout- Avg Volume549.31K Price2.83
Recom1.50 SMA2010.16% SMA509.06% SMA2006.07% Volume560,974 Change2.17%
Aug-10-17Upgrade SunTrust Hold → Buy
Mar-06-17Reiterated Barrington Research Outperform $1.50 → $2.25
Jan-03-17Initiated Lake Street Buy $4.50
Nov-08-16Resumed Jefferies Buy
Aug-12-15Reiterated Dougherty & Company Buy $7 → $4
Aug-11-15Downgrade Sun Trust Rbsn Humphrey Buy → Neutral
Feb-04-14Reiterated Dougherty & Company Buy $8 → $12
Nov-08-13Downgrade Feltl & Co. Strong Buy → Buy $11 → $7.50
Sep-25-13Reiterated Dougherty & Company Buy $15 → $10
Jun-18-13Reiterated Dougherty & Company Buy $15 → $20
Jun-17-13Reiterated Feltl & Co. Strong Buy $17 → $20
Apr-09-13Initiated Feltl & Co. Strong Buy $15
May-10-12Reiterated Dougherty & Company Buy $10 → $13
Sep-28-11Initiated BB&T Capital Mkts Buy $10
Aug-04-09Upgrade Piper Jaffray Neutral → Overweight
Sep-12-08Downgrade Piper Jaffray Buy → Neutral
Aug-13-08Initiated Noble Financial Buy $6.50
May-06-08Reiterated Broadpoint Capital Buy $9 → $6
Apr-30-08Reiterated Dougherty & Company Buy $15 → $8
Feb-15-08Upgrade Broadpoint Capital Neutral → Buy $9
Jun-11-18 06:12AM  Why Is BioScrip (BIOS) Down 2% Since its Last Earnings Report? Zacks
May-30-18 07:00AM  Free Daily Technical Summary Reports on CVS Health and Three Other Healthcare Stocks ACCESSWIRE +6.37%
May-28-18 04:02PM  Edited Transcript of BIOS earnings conference call or presentation 10-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-16-18 09:00AM  BioScrip to Participate in Upcoming Investor Conferences GlobeNewswire
May-11-18 09:11AM  BioScrip (BIOS) Q1 Loss Wider Than Expected, Revenues Beat Zacks
May-10-18 09:24AM  BioScrip: 1Q Earnings Snapshot Associated Press
08:30AM  BioScrip Reports First Quarter 2018 Financial Results GlobeNewswire
May-03-18 08:15AM  Report: Developing Opportunities within Boston Private Financial, Ares Management, BioScrip, Glacier, CBIZ, and Powell Industries Future Expectations, Projections Moving into 2018 GlobeNewswire
Apr-26-18 04:30PM  BioScrip Schedules Release of First Quarter 2018 Financial Results and Conference Call GlobeNewswire
Apr-10-18 05:03PM  BioScrip Incs (NASDAQ:BIOS) Earnings Dropped -62.14%, Did Its Industry Show Weakness Too? Simply Wall St.
Apr-09-18 04:07AM  Why Is BioScrip (BIOS) Down 5.6% Since its Last Earnings Report? Zacks
Apr-04-18 07:20AM  Blog Exposure - Addus Homecare Completes Acquisition of Arcadia Home Care & Staffing for $18.5 Million ACCESSWIRE
Mar-26-18 06:30AM  BioScrip Timely Files Annual Form 10-K, Concludes Accounting Review and Provides Update on Immaterial Financial Statement Corrections GlobeNewswire +6.10%
Mar-21-18 08:20AM  New Research Coverage Highlights Real Goods Solar, LivePerson, Manhattan Associates, Natus Medical, BioScrip, and FBL Financial Group -- Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-20-18 03:09PM  Lifshitz & Miller LLP Announces Investigation of BioScrip, Inc., Civitas Solutions, Inc., Iridex Corp., OHR Pharmaceutical, Inc., Overstock.com, Inc., Syneos Health, Inc., Ubiquiti Networks, Inc. and WageWorks, Inc. PR Newswire
Mar-19-18 12:46PM  What does BioScrip Incs (NASDAQ:BIOS) Balance Sheet Tell Us About Its Future? Simply Wall St.
Mar-16-18 10:50AM  BioScrip's Dull 2017 Earnings a Woe, Core Business Robust Zacks
Mar-15-18 05:30PM  BioScrip Provides Update on Annual Form 10-K Filing Status Business Wire
Mar-14-18 02:58PM  Catalyst Pharmaceuticals Inc (CPRX) and Achillion Pharmaceuticals, Inc. (ACHN) Among Five Cheap Healthcare Stocks To Buy Now Insider Monkey
01:37PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of BioScrip, Inc. -- BIOS Business Wire
08:44AM  Why BioScrip (BIOS) Could Be Positioned for a Slump Zacks
Mar-12-18 10:57AM  BioScrip (BIOS) Loss Widens in Q4, '18 View Holds Promise Zacks
Mar-10-18 06:11AM  Edited Transcript of BIOS earnings conference call or presentation 8-Mar-18 2:00pm GMT Thomson Reuters StreetEvents
Mar-09-18 02:30PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of BioScrip, Inc. Investors Business Wire
Mar-08-18 06:27PM  Milberg Tadler Phillips Grossman LLP Announces Investigation of BioScrip, Inc. PR Newswire -15.47%
05:15PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of BioScrip, Inc. Business Wire
04:00PM  BIOSCRIP INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In BioScrip Inc. To Contact The Firm PR Newswire
03:48PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioScrip, Inc. - BIOS PR Newswire
02:05PM  BioScrip, Inc. (BIOS) Investigated By Block & Leviton LLP For Violations Of The Federal Securities Laws PR Newswire
10:17AM  BioScrip reports 4Q loss Associated Press
08:33AM  BioScrip accounting review identifies 'internal control deficiencies' and 'material weakness' MarketWatch
08:00AM  BioScrip Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
07:30AM  BioScrip, Inc. to Host Earnings Call ACCESSWIRE
Feb-23-18 05:33PM  A Look At The Fair Value Of BioScrip Inc (NASDAQ:BIOS) Simply Wall St.
Feb-22-18 08:00AM  BioScrip Schedules Release of Fourth Quarter and Full Year 2017 Financial Results and Conference Call Business Wire
Feb-09-18 07:30AM  BioScrip Announces U.S. Congress Passage of Medicare Home Infusion Transition Benefit, Effective 2019 Business Wire
Jan-30-18 08:01PM  One Thing To Consider Before Buying BioScrip Inc (NASDAQ:BIOS) Simply Wall St.
Jan-19-18 11:55AM  What Can We Expect for BioScrip Inc (NASDAQ:BIOS) Moving Forward? Simply Wall St.
08:10AM  Analysis: Positioning to Benefit within BioScrip, LPL Financial, Jagged Peak Energy, Standex International, FBL Financial Group, and Nathan's Famous Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jan-08-18 08:00AM  BioScrip Announces Availability of HEMLIBRA® for Hemophilia Patients GlobeNewswire
Dec-29-17 01:15PM  BioScrip Inc (NASDAQ:BIOS): Does 8.3% Earnings Drop In A Year Reflect The Long-Term Trend? Simply Wall St.
Dec-28-17 11:52AM  ETFs with exposure to BioScrip, Inc. : December 28, 2017 Capital Cube
Dec-14-17 10:45AM  Have Investors Already Priced In BioScrip Incs (NASDAQ:BIOS) Growth? Simply Wall St.
Dec-11-17 01:35PM  ETFs with exposure to BioScrip, Inc. : December 11, 2017 Capital Cube
Nov-30-17 01:33PM  ETFs with exposure to BioScrip, Inc. : November 30, 2017 Capital Cube
08:00AM  BioScrip to Host Meetings at the Mizuho Investor Conference GlobeNewswire
Nov-28-17 08:00AM  BioScrip Announces Additions to Senior Leadership Team GlobeNewswire
Nov-22-17 07:28AM  BioScrip, Inc. breached its 50 day moving average in a Bullish Manner : BIOS-US : November 22, 2017 Capital Cube
Nov-20-17 11:50AM  ETFs with exposure to BioScrip, Inc. : November 20, 2017 Capital Cube
Nov-17-17 07:54AM  What does BioScrip Incs (BIOS) Balance Sheet Tell Us Abouts Its Future? Simply Wall St.
Nov-16-17 09:00AM  BioScrip to Present at Bank of America Merrill Lynch 2017 Leveraged Finance Conference GlobeNewswire +6.07%
Nov-09-17 12:07PM  ETFs with exposure to BioScrip, Inc. : November 9, 2017 Capital Cube
08:00AM  BioScrip to Host Meetings at the 8th Annual Craig-Hallum Alpha Select Conference GlobeNewswire
Nov-07-17 07:57AM  BioScrip, Inc. :BIOS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube
Nov-03-17 10:42AM  BioScrip (BIOS) Q3 Loss Wider Than Expected, Revenues Miss Zacks +8.38%
Nov-02-17 05:51PM  Edited Transcript of BIOS earnings conference call or presentation 2-Nov-17 1:00pm GMT Thomson Reuters StreetEvents -20.42%
10:22AM  Is BioScrip Inc (BIOS) Expensive For A Reason? A Look At The Intrinsic Value Simply Wall St.
09:23AM  BioScrip reports 3Q loss Associated Press
08:00AM  BioScrip Reports Third Quarter 2017 Financial Results GlobeNewswire
07:40AM  BioScrip, Inc. to Host Earnings Call ACCESSWIRE
Oct-31-17 08:00AM  BioScrip to Present at Stephens Fall Investment Conference GlobeNewswire
Oct-30-17 11:27AM  ETFs with exposure to BioScrip, Inc. : October 30, 2017 Capital Cube
Oct-16-17 08:00AM  BioScrip to Host Third Quarter Results Call GlobeNewswire
Oct-13-17 10:33AM  ETFs with exposure to BioScrip, Inc. : October 13, 2017 Capital Cube
Oct-05-17 08:00AM  BioScrip Announces Availability of ALS Home Infusion Therapy GlobeNewswire
Oct-03-17 08:12AM  BioScrip, Inc. breached its 50 day moving average in a Bullish Manner : BIOS-US : October 3, 2017 Capital Cube
Sep-29-17 08:57AM  BioScrip, Inc. :BIOS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-13-17 01:46PM  Edited Transcript of BIOS earnings conference call or presentation 8-Aug-17 1:00pm GMT Thomson Reuters StreetEvents
Sep-12-17 08:45AM  BioScrip: Cost Cuts and Potential Legislation Sparks Analyst Coverage ACCESSWIRE
Sep-01-17 05:35AM  BioScrip's Infusion Business Strong, Dull 2017 View a Drag (Revised) Zacks
Aug-29-17 09:38PM  BioScrip, Inc. Value Analysis (NASDAQ:BIOS) : August 30, 2017 Capital Cube
Aug-23-17 09:46AM  BioScrip, Inc. breached its 50 day moving average in a Bearish Manner : BIOS-US : August 23, 2017 Capital Cube
Aug-21-17 11:07AM  BioScrip's Infusion Business Strong, Dull 2017 View a Drag Zacks
Aug-12-17 11:35PM  Edited Transcript of BIOS earnings conference call or presentation 4-May-17 1:00pm GMT Thomson Reuters StreetEvents
Aug-11-17 08:25AM  BioScrip (BIOS) Shows Strength: Stock Adds 6.6% in Session Zacks +5.19%
06:44AM  BioScrip (BIOS) Gains on CORE Initiatives, Competition Rife Zacks
Aug-09-17 09:46AM  BioScrip (BIOS) Q2 Loss Wider Than Expected, Revenues Miss Zacks
Aug-08-17 11:54PM  BioScrip reports 2Q loss Associated Press
08:00AM  BioScrip Reports Second Quarter 2017 Financial Results GlobeNewswire
06:30AM  Investor Network: BioScrip, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 01:44PM  BioScrip, Inc. -- Moody's rates BioScrip's new debt; Caa2 CFR affirmed Moody's
Jul-27-17 08:30AM  First Choice Appoints New CFO to Help Lead Company Through Next Phase of Strategic Execution GlobeNewswire
Jul-26-17 08:00AM  BioScrip Applauds US House Passage of HR3178, the Medicare Part B Improvement Act of 2017 GlobeNewswire
Jul-17-17 09:00AM  BioScrip To Host Second Quarter Results Call GlobeNewswire
Jul-10-17 09:30AM  Zacks.com featured highlights: Ardelyx, Novavax, BioScrip, Layne Christensen and Resonant Zacks
Jul-07-17 08:41AM  5 Breakout Stocks Offering Phenomenal Returns Zacks
Jun-30-17 09:11AM  BioScrip (BIOS) Strong on Infusion, Reimbursement a Drag Zacks
Jun-29-17 08:30AM  BioScrip Announces New Senior Note Facilities GlobeNewswire -12.71%
Jun-09-17 03:41AM  Why Is BioScrip (BIOS) Up 15.3% Since the Last Earnings Report? Zacks
Jun-05-17 08:00AM  Today's Research Reports on Stocks to Watch: Synergy Pharmaceuticals and Bioscrip Inc. Accesswire
May-30-17 08:00AM  BioScrip Provides Update on UnitedHealthcare Contract GlobeNewswire
May-24-17 08:00AM  BioScrip to Present at the Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-23-17 12:29PM  ETFs with exposure to BioScrip, Inc. : May 23, 2017 Capital Cube
May-11-17 04:17PM  ETFs with exposure to BioScrip, Inc. : May 11, 2017 Capital Cube
10:07AM  Dull Q1 Earnings & Tough Industry Spell Trouble for BioScrip Zacks
May-09-17 10:46AM  BioScrip, Inc. :BIOS-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 Capital Cube
May-08-17 07:41AM  Edited Transcript of BIOS earnings conference call or presentation 4-May-17 1:00pm GMT Thomson Reuters StreetEvents
May-05-17 10:47AM  BioScrip (BIOS) Q1 Loss Narrower than Expected, Sales Miss Zacks
May-04-17 09:14AM  BioScrip reports 1Q loss Associated Press
08:00AM  BioScrip Reports First Quarter 2017 Financial Results GlobeNewswire
BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient's homes, outpatient clinics, nursing facilities, physician's offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coliseum Capital Management, LDirectorMay 02Option Exercise0.0049,66901,938,660May 04 05:58 PM
Deitsch StephenChief Financial OfficerNov 09Buy2.0310,00020,30010,000Nov 13 04:00 PM
GREENLEAF DANIEL EChief Executive OfficerNov 09Buy2.0315,00030,49531,000Nov 13 03:58 PM
Bronfein Michael GDirectorSep 15Sale2.6927,00072,733129,669Sep 19 03:59 PM
Coliseum Capital Management, LDirectorSep 07Sale2.881,275,6373,673,8351,888,991Sep 07 07:09 PM
Coliseum Capital Management, LDirectorSep 06Sale2.961,349,4753,994,4463,164,628Sep 07 07:09 PM
Coliseum Capital Management, LDirectorSep 05Sale3.08221,829683,2334,514,103Sep 07 07:09 PM
Coliseum Capital Management, LDirectorAug 17Sale3.05554,4761,691,1524,735,932Aug 17 07:45 PM
Coliseum Capital Management, LDirectorAug 16Sale3.11115,702359,8335,290,408Aug 17 07:45 PM
Coliseum Capital Management, LDirectorAug 15Sale3.15216,300681,3455,406,110Aug 17 07:45 PM